Advertisement
Screener

Cue Biopharma, Inc. (CUE) Graph

2.8 / 5 stars · 68/120 Roast Me

CUE Revenue Flow

CUE Graph summary

Cue Biopharma, Inc. (CUE). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Cue Biopharma, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.01B $0.10B$-0.09B$0.05B$0.05B$-0.09B$0.07B$-0.15B Revenue from contracts with customers, excluding assessed tax$0.01BDeclared revenue$0.01B Operating expenses$0.10BOperating income$-0.09BResearch and development$0.05BGeneral and administrative$0.05BOther expense, net$0.07BNet income$-0.15B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
MACROGENICS INC (MGNX)United States$0.242B-20.11
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Advertisement